Leah Kuntz

1 day ago | psychiatrictimes.com | Leah Kuntz

Ecopipam for Tourette syndrome (TS) was found to be safe and effective in a 12-month, open-label extension (OLE) of a phase 2b study. Ecopipam 1.8 mg/kg/day reduced tic severity and improved quality of life in children and adolescents with TS, with no evidence of tachyphylaxis.

2 days ago | psychiatrictimes.com | Leah Kuntz

On June 13, 2025, the US Food and Drug Administration (FDA) officially eliminated the clozapine REMS, and all REMS operations ceased.1Although clozapine still carries a risk of severe neutropenia, the FDA has determined that the clozapine REMS is no longer necessary, and by eliminating the REMS, they expect to improve access to clozapine.

1 week ago | psychiatrictimes.com | Leah Kuntz

US Senators Shelley Moore Capito (R-West Virginia) and Jeanne Shaheen (D-New Hampshire) have reintroduced bipartisan legislation to increase access to prescription digital therapeutics (PDTs).

1 week ago | psychiatrictimes.com | Leah Kuntz

The government has always played an important role in health care: it has established agencies to ensure drug safety, created Medicare and Medicaid to improve access, etc. Recent changes, however, are actively altering the practice of medicine and are posed to have a deep and lasting psychiatric impact on patients. Although this is a rapidly evolving situation, here is a closer look at the facts as this issue went to press.

2 weeks ago | psychiatrictimes.com | Leah Kuntz

Psychiatric Times is committed to promoting diversity, equity, and inclusion to improve patient outcomes in psychiatry. The publication encourages professionals to share insights on addressing diversity, using cultural psychotherapy, and offering practice tips. Practitioners are urged to engage effectively with patients from diverse backgrounds and share relevant experiences.